LGALS9 and neoplasm: We found >85% consistency of the ligand–receptor interactions (i.e., SPP1-PTGER4 and LGALS9-SLC1A5) between tumor cells and TAMs using the two methods, suggesting that the identified pairs are stable (Supplementary Fig. 14a).